Neurology News and Research

Latest Neurology News and Research

The Miriam Hospital receives Primary Stroke Center certification for fifth consecutive year

The Miriam Hospital has for the fifth time been designated by the Joint Commission as a Primary Stroke Center.

16 Sep 2014

Bayer, Orion begin patient enrollment in ODM-201 Phase III trial for castration-resistant prostate cancer

Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development.

16 Sep 2014

New class of compounds protect brain cells from traumatic brain injury

A new class of compounds has now been shown to protect brain cells from the type of damage caused by blast-mediated traumatic brain injury (TBI).

12 Sep 2014

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

11 Sep 2014

Study looks at blood type and risk of cognitive impairment

People with blood type AB may be more likely to develop memory loss in later years than people with other blood types, according to a study published in the September 10, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

11 Sep 2014

Researchers create new vestibular test to add to comprehensive concussion evaluation

Researchers at UPMC and the University of Pittsburgh have created a new, 5- to 10-minute test that could be added to a clinician's concussion evaluation toolkit for a more comprehensive assessment of the injury.

11 Sep 2014

Pollution in many cities threatens brain development in children

Pollution in many cities threatens the brain development in children. Findings by University of Montana Professor Dr. Lilian Calder-n-Garcidue-as, MA, MD, Ph.D., and her team of researchers reveal that children living in megacities are at increased risk for brain inflammation and neurodegenerative changes, including Alzheimer's or Parkinson's disease.

11 Sep 2014

Neurologists implant neurostimulator in brain to control seizures

It has been 30 days since neurologists at the University of Alabama at Birmingham turned on the neurostimulator implanted in Sarah Conner's brain to control her seizures.

9 Sep 2014

Alzheimer's disease report success in harnessing mouse's immune system to attack toxic proteins

Alzheimer's disease experts at NYU Langone Medical Center and elsewhere are reporting success in specifically harnessing a mouse's immune system to attack and remove the buildup of toxic proteins in the brain that are markers of the deadly neurodegenerative disease.

9 Sep 2014

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Transparency Life Sciences, LLC (TLS), the world's first clinical-stage drug development company based on open innovation, today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive therapy for multiple sclerosis (MS).

8 Sep 2014

Findings may help develop biomarkers to identify HIV patients at risk of dementia

Since the introduction of the combination anti-retroviral therapy (cART) in the mid-90s, the life expectancy of HIV patients has significantly improved. As a result, long-term complications are becoming more relevant: almost every second HIV patient is affected by neurocognitive disorders, which can lead to dementia.

4 Sep 2014

Researchers examine link between sleep difficulties and brain volume

Sleep difficulties may be linked to faster rates of decline in brain volume, according to a study published in the September 3, 2014, online issue of Neurology-, the medical journal of the American Academy of Neurology.

4 Sep 2014

Robotics engineers demonstrate viability of direct brain-to-brain communication in humans

In a first-of-its-kind study, an international team of neuroscientists and robotics engineers have demonstrated the viability of direct brain-to-brain communication in humans.

4 Sep 2014

Transplantation of B10 cells helps inhibit development of bladder fibrosis post SCI

A team of researchers from Korea and Canada have found that transplantation of B10 cells (a stable immortalized human bone marrow derived -mesenchymal stem cell line; B10 hMSC) directly into the bladder wall of mice modeled with spinal cord injury (SCI) helped inhibit the development of bladder fibrosis and improved bladder function by promoting the growth of smooth muscle cells in the bladder.

4 Sep 2014

Using iPS technology researchers develop new therapies for Parkinson's disease and ALS

Dresden. Dr. Jared Sterneckert is entering the research area "Neurodegenerative Diseases" of the DFG Research Center and Cluster of Excellence at the TU Dresden as a new junior group leader. Since 2006, he has led a team working at the "Max Planck Institute for Molecular Biomedicine" in Münster to develop models of Parkinson's disease and amyotrophic lateral sclerosis.

3 Sep 2014

Flow through pain-sensing molecule helps worms adapt to pain

When you accidentally touch a hot oven, you rapidly pull your hand away. Although scientists know the basic neural circuits involved in sensing and responding to such painful stimuli, they are still sorting out the molecular players.

2 Sep 2014

Vasopressin more effective for cardiopulmonary resuscitation

Epinephrine has been shown to be a first-choice drug for cardiopulmonary resuscitation. Nevertheless, its β-adrenergic effect probably increases myocardial oxygen consumption and leads to severe cardiac and cerebral injuries; moreover, epinephrine does not elevate long-term survival rates.

29 Aug 2014

$Study: Young athletes need to avoid continuous repetitive activity to decrease risk of pars fracture$

Study: Young athletes need to avoid continuous repetitive activity to decrease risk of pars fracture

Young athletes today often participate in sports year round and with increasingly competitive club and school sports, it has become common to choose one sport to specialize at a young age. While this specialization may seem like a competitive edge, new Northwestern Medicine research suggests that repetitive activity in just one sport, high impact or not, may not be a great idea for growing athletes.

29 Aug 2014

New MS treatment found safe, tolerable in phase I clinical trials

A new treatment under investigation for multiple sclerosis (MS) is safe and tolerable in phase I clinical trials, according to a study published August 27, 2014, in Neurology Neuroimmunology & Neuroinflammation, a new online-only, freely accessible, specialty medical journal.

28 Aug 2014

Mindfulness training can brighten outlook on life for person with memory loss and caregiver

Mindfulness training for individuals with early-stage dementia and their caregivers together in the same class was beneficial for both groups, easing depression and improving sleep and quality of life, reports new Northwestern Medicine study.

26 Aug 2014

Neurology News and Research

Latest Neurology News and Research

The Miriam Hospital receives Primary Stroke Center certification for fifth consecutive year

Bayer, Orion begin patient enrollment in ODM-201 Phase III trial for castration-resistant prostate cancer

New class of compounds protect brain cells from traumatic brain injury

FDA approves Contrave extended-release tablets for chronic weight management

Study looks at blood type and risk of cognitive impairment

Researchers create new vestibular test to add to comprehensive concussion evaluation

Pollution in many cities threatens brain development in children

Neurologists implant neurostimulator in brain to control seizures

Alzheimer's disease report success in harnessing mouse's immune system to attack toxic proteins

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Findings may help develop biomarkers to identify HIV patients at risk of dementia

Researchers examine link between sleep difficulties and brain volume

Robotics engineers demonstrate viability of direct brain-to-brain communication in humans

Transplantation of B10 cells helps inhibit development of bladder fibrosis post SCI

Using iPS technology researchers develop new therapies for Parkinson's disease and ALS

Flow through pain-sensing molecule helps worms adapt to pain

Vasopressin more effective for cardiopulmonary resuscitation

Study: Young athletes need to avoid continuous repetitive activity to decrease risk of pars fracture

New MS treatment found safe, tolerable in phase I clinical trials

Mindfulness training can brighten outlook on life for person with memory loss and caregiver

Everything you need to know about epilepsy eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Neurology News and Research

Latest Neurology News and Research

Everything you need to know about epilepsy eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in